Christopher Duncan-Lewis
Rapt Therapeutics (United States)
ORCID: 0000-0001-7775-5856Biochemistry, Genetics and Molecular BiologyMedicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 3 papers. Top paper: βCytoplasmic mRNA decay represses RNA polymerase II transcription during early apoptosisβ.
N/A
33 citations
Ella Hartenian, Valeria M. King, Britt A. Glaunsinger, Christopher Duncan-Lewis
N/A
19 citations
Anupama Jha, Jesse Humenik, Louis R. Ghanem, Andrew Kromer, Christopher Duncan-Lewis +5 more
N/A
1 citations
Ella Hartenian, Valeria M. King, Britt A. Glaunsinger, Christopher Duncan-Lewis